Implantable Cardioverter–Defibrillators after Myocardial Infarction
- 20 November 2008
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 359 (21), 2245-2253
- https://doi.org/10.1056/nejmra0803409
Abstract
Patients with a history of myocardial infarction and a reduced ejection fraction are at increased risk for life-threatening ventricular arrhythmias. Which of these patients are the most appropriate candidates for implantable cardioverter–defibrillator (ICD) therapy is unclear. Factors influencing the decision are discussed.Keywords
This publication has 57 references indexed in Scilit:
- Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or BothThe New England Journal of Medicine, 2005
- Sudden Death Due to Cardiac ArrhythmiasThe New England Journal of Medicine, 2001
- Extended Mortality Benefit of Early Postinfarction ReperfusionCirculation, 1998
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesThe New England Journal of Medicine, 1997
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionThe New England Journal of Medicine, 1992
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990
- Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPSThe American Journal of Cardiology, 1988
- Risk factors for sudden death after acute myocardial infarction: Two-year follow-upThe American Journal of Cardiology, 1984
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984
- Risk Stratification and Survival after Myocardial InfarctionThe New England Journal of Medicine, 1983